BioSenic SA | BIOS Annual Report & Investor Relations Data
ISIN
BE0974280126
Ticker
BIOS
Sector
Industry
Country
Belgium
Year Founded
2006
ISIN
BE0974280126
Ticker
BIOS
Sector
Industry
Country
Belgium
Year Founded
2006
BioSenic is an innovative company with the objective of addressing important unmet medical needs in the areas of innate immunity, inflammation and organ/function repair.
Our expertise is focused on bone cell therapy and the therapeutic use of arsenic trioxide (As2O3). BioSenic aims to become a leading company in the field of regenerative and immune medicine by developing innovative products for bone and autoimmune and inflammatory diseases.
BioSenic has a broad and diverse portfolio of solutions in clinical development in a variety of therapeutic areas targeting markets characterized by significant unmet medical needs and limited innovation.
Worldwide
| Type | Document | Details | Language | Filing Date | File Number |
|---|
Soon you'll be able to search through every word in BioSenic SA's all filings. Find mentions of specific topics, track strategic initiatives, or analyze historical data.
Access comprehensive European stock market filings data through a single, powerful API.
1,5M+
filings covered
18
European countries
30min
max latency
1 API
for all filings
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 16.08.2024 | Rieger Francois | Board | Sell | EUR 25,000.00 |
| 06.08.2024 | Rieger Francois | Board | Sell | EUR 7,186.87 |
| 05.08.2024 | POMI SCHNEITER VERONIQUE | Board | Sell | EUR 4,331.47 |
| 02.08.2024 | POMI SCHNEITER VERONIQUE | Board | Sell | EUR 1,609.37 |
| 01.08.2024 | Rieger Francois | Board | Sell | EUR 11,463.87 |
| 01.08.2024 | POMI SCHNEITER VERONIQUE | Board | Sell | EUR 1,246.03 |
| 31.07.2024 | POMI SCHNEITER VERONIQUE | Board | Sell | EUR 4,685.07 |
| 30.07.2024 | POMI SCHNEITER VERONIQUE | Board | Sell | EUR 3,348.20 |
| 29.07.2024 | POMI SCHNEITER VERONIQUE | Board | Sell | EUR 3,430.62 |
| 24.07.2024 | POMI SCHNEITER VERONIQUE | Board | Sell | EUR 21,033.10 |
We currently don't have information about the management or supervisory board for this company. This information will be updated as soon as it becomes available.
VSC
Sector
Health Care
Country
Germany
ISIN
DE000A3E5C40
Founded
1997
4SC focuses on the development of novel small molecule drugs that target key mechanisms of cancer development, such as histone …
ABNX
Sector
Health Care
Country
France
ISIN
FR0012616852
Founded
ABIONYX Pharma is a new-generation biotech company that aims to contribute to health through innovative therapies in indications where there …
ABLI
Sector
Health Care
Country
Sweden
ISIN
SE0002575340
Founded
2000
Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when …
AB
Sector
Health Care
Country
France
ISIN
FR0010557264
Founded
2001
AB Science is a late-clinical-stage French company founded in 2001 by a team of scientists with the goal of developing …
ALACT
Sector
Health Care
Country
France
ISIN
FR0014005OJ5
Founded
Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of …
ACTI
Sector
Health Care
Country
Sweden
ISIN
SE0001137985
Founded
1998
Active Biotech develops pharmaceutical products within medical areas where the immune system is of significant importance, including cancer and inflammatory …